Vaccines and Biotechnology city
Vaccines and Biotechnology City (VBC) is a national public–private initiative dedicated to strengthening health security, achieving self-sufficiency, and localizing the production of human and veterinary vaccines in Egypt.
Building on more than 15 years of expertise through MEVAC for Vaccines, a pioneering American–Egyptian company, VBC stands at the forefront of vaccine innovation, technology transfer, and local talent development.
Guided by scientific research, global partnerships, and a strong commitment to public health, VBC actively supports education, training, and volunteering programs to empower future generations while fostering economic growth across Egypt, Africa, and the Middle East.
We embrace the One Health approach — promoting equity and sustainability for humans, animals, and the environment alike.
To pioneer a new era of regional health resilience, making Egypt a driving force in Africa’s journey toward vaccines & Biotechnological products self-sufficiency through a holistic “One Health” approach.
By 2030, to establish and operationalize a self-sufficient, full- cycle development framework that guarantees sustainable vaccine access and enables a rapid, "One Health" guided response to health emergencies across all served regions
